External Drainage System Collection Bag, REF: NT821732C, STERILEEO, Rx only
FDA Device Recall #Z-0634-2024 — Class II — November 28, 2023
Recall Summary
| Recall Number | Z-0634-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 28, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Natus Medical Incorporated |
| Location | San Diego, CA |
| Product Type | Devices |
| Quantity | 2,686 units |
Product Description
External Drainage System Collection Bag, REF: NT821732C, STERILEEO, Rx only
Reason for Recall
Sterility assurance cannot be guaranteed for external drainage systems due to incomplete bioburden testing.
Distribution Pattern
US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV.
Lot / Code Information
UDI: 00382830050562/ Lot #: 1FX0004951660 1FX0004951658 1FX0004951659 1FX0005040450 1FX0005040451 1FX0005040452 1FX0005040453 1FX0005040454 1FX0005040457 1FX0005040456 1FX0005079696 1FX0005126475 1FX0005126474 1FX0005040455
Other Recalls from Natus Medical Incorporated
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0635-2024 | Class II | EDS 3 CSF External Drainage System, REF: NT821... | Nov 28, 2023 |
| Z-0735-2023 | Class II | The Natus Cranial Access Kit is designed to be ... | Nov 18, 2022 |
| Z-2701-2017 | Class II | The Olympic Pasteurmatic 3000 and Olympic Paste... | May 22, 2017 |
| Z-1924-2017 | Class II | Second generation neoBLUE LED Phototherapy Ligh... | Apr 3, 2017 |
| Z-0770-2017 | Class II | Natus neoBLUE blanket LED Phototherapy system, ... | Oct 28, 2016 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.